| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TESARO INC | 8,854,255 | 520,542,000 | 27.18% | ||
| 2 | GROUPON INC | 44,172,953 | 222,190,000 | 11.60% | ||
| 3 | ARDELYX INC COM | 10,294,096 | 164,397,000 | 8.58% | ||
| 4 | SUPERNUS PHARMACEUTICALS INC COM | 7,641,250 | 129,748,000 | 6.78% | ||
| 5 | EPIZYME INC COM | 5,149,740 | 123,594,000 | 6.45% | ||
| 6 | OPOWER INC | 8,997,290 | 103,559,000 | 5.41% | ||
| 7 | CLOVIS ONCOLOGY INC | 1,139,890 | 100,174,000 | 5.23% | ||
| 8 | GLYCOMIMETICS INC | 8,575,135 | 68,172,000 | 3.56% | ||
| 9 | DERMIRA INC | 3,506,649 | 61,542,000 | 3.21% | ||
| 10 | NEVRO CORP | 993,428 | 53,397,000 | 2.79% | ||
| 11 | VITAE PHARMACEUTICALS INC | 2,613,199 | 37,630,000 | 1.97% | ||
| 12 | AEROHIVE NETWORKS INC | 4,681,455 | 32,677,000 | 1.71% | ||
| 13 | LOXO ONCOLOGY INC COM | 1,792,207 | 32,313,000 | 1.69% | ||
| 14 | TREVENA INC | 4,811,691 | 30,121,000 | 1.57% | ||
| 15 | Tracon Pharmaceuticals Inc | 1,889,652 | 21,410,000 | 1.12% | ||
| 16 | TRIVASCULAR TECHNOLOGIES INC | 3,945,191 | 21,107,000 | 1.10% | ||
| 17 | CARE COM INC COM | 3,260,989 | 19,305,000 | 1.01% | ||
| 18 | * LEXICON PHARMACEUTICALS INC COM | 2,382,286 | 19,177,000 | 1.00% | ||
| 19 | Orexigen Therapeutics, Inc. | 3,709,000 | 18,360,000 | 0.96% | ||
| 20 | Zosano Pharma Corp | 2,158,543 | 15,649,000 | 0.82% | ||
| 21 | SUNESIS PHARMACEUTICALS INC | 4,659,333 | 14,025,000 | 0.73% | ||
| 22 | MILLENNIAL MEDIA INC | 8,224,752 | 13,324,000 | 0.70% | ||
| 23 | TARGACEPT INC | 4,566,666 | 12,741,000 | 0.67% | ||
| 24 | ARCA BIOPHARMA INC COM NEW | 10,221,465 | 11,755,000 | 0.61% | ||
| 25 | ZHONE TECHNOLOGIES INC NEW | 4,781,290 | 10,710,000 | 0.56% | ||
| 26 | RIGEL PHARMACEUTICAL INC | 3,243,150 | 10,411,000 | 0.54% | ||
| 27 | ROKA BIOSCIENCE INC | 3,220,433 | 8,373,000 | 0.44% | ||
| 28 | EXELIXIS INC | 2,207,000 | 8,298,000 | 0.43% | ||
| 29 | AURINIA PHARMACEUTICALS INC | 2,546,843 | 7,691,000 | 0.40% | ||
| 30 | CHANNELADVISOR CORP COM | 556,692 | 6,652,000 | 0.35% | ||
| 31 | CVENT INC | 244,106 | 6,293,000 | 0.33% | ||
| 32 | PARATEK PHARMACEUTICALS INC | 173,892 | 4,481,000 | 0.23% | ||
| 33 | ArQule Inc | 2,520,316 | 4,033,000 | 0.21% | ||
| 34 | Agile Therapeutics, Inc. | 133,488 | 1,147,000 | 0.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001512848-15-000004, filed 2015.07.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
